Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-22

Clinical Trial Update: Registry of Asthma Characterization and Recruitment 3 (RACR3)

View source ↗

Summary

RACR3 is an ongoing registry to characterize asthma and support recruitment, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Asthma | Status: RECRUITING